Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational ...

Though Pfizer Inc.’s work on a PD-1-targeting antibody has trailed far behind that of its fellow big pharmas, the company could be the first to market in treatment-naïve, high-risk non-muscle invasive ...

H.C. Wainwright analyst Andres Maldonado keeps a Buy rating on CG Oncology (CGON) with a $75 price target after Pfizer (PFE) announced positive ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

NEW YORK, NY. USA I January 10, 2025 I Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating ...

Pfiz­er said its ex­per­i­men­tal an­ti-PD-1 drug best­ed the cur­rent stan­dard of care in a type of blad­der can­cer where ...

Pemazyre and Lytgobi are already launched in Japan for FGFR2-mutated BTC, but at the moment Balversa is only approved for bladder cancer. Elsewhere, Pemazyre was approved in the US for the BTC ...

The chief public health officer says even though cases are rising, the health department hasn't declared an outbreak.

Companies seeking to benefit from campaign promises to cut regulations and taxes are ditching diversity and climate initiatives; ‘EVERYBODY WANTS TO BE MY FRIEND!!!’ ...

Supreme Court Seems Poised to Uphold Law That Could Ban TikTok The justices are expected to rule quickly in the case, which pits national security concerns about China against free speech ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total ...